Medicare Enrolled

Dr. Pallavy Reddy, MD

Endocrinology · Dublin, OH
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
7281 SAWMILL ROAD, Dublin, OH 43016
6147640707
In practice since 2005 (20 years)
NPI: 1740277664 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Reddy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Reddy? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Reddy

Dr. Pallavy Reddy is an endocrinology specialist in Dublin, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Reddy performed 15,015 Medicare services across 1,447 unique beneficiaries.

Between the years covered by Open Payments, Dr. Reddy received a total of $32,786 from 53 pharmaceutical and/or device companies across 1068 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Reddy is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 2% volume in OH $32,786 industry payments

Medicare Practice Summary

Medicare Utilization ↗
15,015
Medicare services
Top 2% in OH for endocrinology
1,447
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~751 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 12,780 $18 $30
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
581 $82 $191
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
418 $123 $239
Blood glucose test using hand-held instrument
A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels.
392 $3 $10
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
379 $25 $56
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
213 $11 $47
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
189 $9 $21
Ultrasound of head and neck soft tissue
This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation.
38 $72 $289
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
25 $56 $133
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$32,786
Total received (2018-2024)
Avg $4,684/year across 7 years
Top 14% in OH for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
1,068
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$20,684 (63.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,102 (36.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$923
2023
$566
2022
$890
2021
$539
2020
$6,574
2019
$13,806
2018
$9,487

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Dexcom, Inc.
$160
Medtronic, Inc.
$84
Novo Nordisk Inc
$73
Xeris Pharmaceuticals, Inc.
$62
Corcept Therapeutics
$61
IBSA Pharma Inc.
$57
SANOFI-AVENTIS U.S. LLC
$51
Amgen Inc.
$46
Novartis Pharmaceuticals Corporation
$43
Boehringer Ingelheim Pharmaceuticals, Inc.
$43
Lilly USA, LLC
$41
Abbott Laboratories
$36
PFIZER INC.
$28
Amphastar Pharmaceuticals, Inc.
$22
Insulet Corporation
$21
Amneal Pharmaceuticals LLC
$18
Esperion Therapeutics, Inc.
$18
CeQur Corporation
$16
Chiesi USA, Inc.
$15
Averitas Pharma Inc.
$14
Antares Pharma, Inc.
$14
Top 3 companies account for 34.3% of 2024 payments
All-time payments by company (2018-2024) ›
Tandem Diabetes Care, Inc.
$20,709
Novo Nordisk Inc
$2,106
Lilly USA, LLC
$769
Dexcom, Inc.
$730
Amgen Inc.
$702
SANOFI-AVENTIS U.S. LLC
$670
Mannkind Corporation
$621
Insulet Corporation
$499
Boehringer Ingelheim Pharmaceuticals, Inc.
$474
Janssen Pharmaceuticals, Inc
$469
AstraZeneca Pharmaceuticals LP
$458
Corcept Therapeutics
$357
Abbott Laboratories
$338
Amarin Pharma Inc.
$330
Amneal Pharmaceuticals LLC
$315
Radius Health, Inc.
$306
AbbVie, Inc.
$304
Regeneron Healthcare Solutions, Inc.
$265
Merck Sharp & Dohme Corporation
$233
Valeritas, Inc.
$217
Gemini Laboratories, LLC
$195
PFIZER INC.
$167
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$139
Endo Pharmaceuticals Inc.
$132
Xeris Pharmaceuticals, Inc.
$123
MannKind Corporation
$114
Aegerion Pharmaceuticals, Inc.
$110
Shire North American Group Inc
$105
IBSA Pharma Inc.
$103
LifeScan, Inc.
$97
Medtronic, Inc.
$84
ABBVIE INC.
$83
AbbVie Inc.
$48
Novartis Pharmaceuticals Corporation
$43
DEXCOM, INC.
$38
Antares Pharma, Inc.
$36
Kowa Pharmaceuticals America, Inc.
$35
Horizon Therapeutics plc
$29
Alexion Pharmaceuticals, Inc.
$22
Amphastar Pharmaceuticals, Inc.
$22
Companion Medical, Inc.
$21
ASCEND Therapeutics US, LLC
$18
Esperion Therapeutics, Inc.
$18
Supernus Pharmaceuticals, Inc.
$17
Medtronic MiniMed, Inc.
$17
Bayer HealthCare Pharmaceuticals Inc.
$16
CeQur Corporation
$16
Chiesi USA, Inc.
$15
Averitas Pharma Inc.
$14
Allergan Inc.
$13
Allergan, Inc.
$11
Ascensia Diabetes Care US Inc.
$11
Clarus Therapeutics Inc.
$3
Top 3 companies account for 71.9% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AVEED · Androgel · BAQSIMI · BASAGLAR · BINOSTO · CONTOUR NEXT ONE Meter · CREON · CYCLOSET · CeQur Simplicity · Creon · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · FARXIGA · FORTEO · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMALOG · HUMULIN · INVOKANA · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LANTUS · LEQVIO · LICART · Livalo · MINIMED 780G · MOUNJARO · MYALEPT · MYCAPSSA · Macrilen · Minimed 530G · NASCOBAL · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · OT Verio Flex Starter Kit · Omnipod · OneTouch · Otrexup · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Prolia · QUTENZA · RECORLEV · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STEGLATRO · STEGLUJAN · SYNTHROID · Saxenda · Strensiq · Synthroid · TEPEZZA · TLANDO · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UNITHROID · V-GO · Vascepa · Victoza · Wegovy · XARELTO · XYOSTED · Xultophy 100/3.6 · ZENPEP · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (63%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware.

Looking for an endocrinology specialist in Dublin?
Compare endocrinologists in the Dublin area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
65
Per 100K population
4.9
County median income
$73,795
Nearest hospital
DUBLIN METHODIST HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Reddy is a mixed practice specialist, with above-average Medicare volume (top 2% in OH), with speaking/promotional industry engagement in the top 14% of OH peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Reddy experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Reddy performed 12,780 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Reddy receive payments from pharmaceutical companies?
Yes. Dr. Reddy received a total of $32,786 from 53 companies across 1,068 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Reddy's costs compare to other endocrinologists in Dublin?
Dr. Reddy's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Reddy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →